Mirae Asset Global Investments
OMGA

Mirae Asset Global Investments’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Mirae Asset Global Investments’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,047
Closed -$32.4K – 2616
2023
Q3 		$32.4K Buy
15,047
+51
+0.3% +$204 ﹤0.01% 2557
2023
Q2 		$84K Buy
+14,996
New +$117K ﹤0.01% 2550

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's OMGA Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2023, closing a stake of 15,047 shares — an estimated $32.4K sold.

Mirae Asset Global Investments first reported a position in OMGA in Q2 2023 and held it in 2 quarters. The position peaked at $84K in Q2 2023. 63 funds tracked by Wall St. Rank hold OMGA as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,047 Omega Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $32.4K.
  • Mirae Asset Global Investments first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Mirae Asset Global Investments's Omega Therapeutics, Inc. Common Stock position peaked at $84K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.